Exosome and Biotherapeutic Strategies for Dermatological and Oncological Skin Complications
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Biopharmaceuticals".
Deadline for manuscript submissions: 25 December 2025 | Viewed by 280
Special Issue Editors
Interests: exosome-based therapies in aesthetic and regenerative medicine; plant-derived exosomes for skin repair and anti-inflammatory modulation; biotherapeutic strategies for scar treatment and wound healing; regenerative protocols for post-laser and post-procedural skin recovery; skin complications associated with oncologic therapies and their management; evidence-based integration of injectables, energy-based devices, and regenerative agents
Interests: advanced therapy medicinal products (ATMP); mesenchymal stem cells; keratinocytes; fibroblasts; chondrocytes; regenerative medicine; cell banking; burn treatment; chronic wound healing; autologous cell therapy
Special Issue Information
Dear Colleagues,
This Special Issue explores the expanding role of exosomes and biotherapeutic strategies in the treatment and regeneration of the skin across a wide spectrum of dermatologic conditions. As cell-free agents with regenerative, anti-inflammatory, and immunomodulatory properties, exosomes hold great promise for applications ranging from wound healing and scar remodeling to aesthetic skin rejuvenation and the management of inflammatory dermatoses. In recent years, their use has also gained attention in supporting skin recovery following energy-based procedures such as laser therapy.
Particular focus is also given to the role of exosomes in managing oncologic skin complications, including adverse cutaneous reactions caused by chemotherapy, radiotherapy, targeted therapies (e.g., EGFR and BRAF/MEK inhibitors), and immunotherapies. We invite original research articles, clinical case reports, and reviews that examine therapeutic mechanisms, safety, delivery strategies, and treatment outcomes. Interdisciplinary contributions from dermatology, oncology, and regenerative medicine are especially encouraged to foster integrated, patient-centered care models.
Keywords: Exosomes; dermatology; biotherapeutics; regenerative medicine; wound healing; aesthetic dermatology; skin complications; cancer therapy; laser-assisted recovery; translational skin therapy.
The scope of this Special Issue includes, but is not limited to:
- Exosome-based approaches for skin regeneration, rejuvenation, and scar modulation;
- Wound healing and post-procedural recovery (e.g., after laser or microneedling);
- Management of inflammatory skin diseases using exosomes;
- Treatment of oncologic skin complications caused by chemotherapy, radiotherapy, targeted therapies, and immunotherapy;
- Clinical studies and real-world case series;
- Advances in delivery systems and formulation of exosome-based therapeutics;
- Safety, regulatory, and standardization considerations in dermatologic applications;
- Interdisciplinary strategies bridging dermatology, oncology, and aesthetic medicine.
Dr. Lidia Majewska
Dr. Jacek M. Kijowski
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- exosomes
- skin cancer
- dermatological therapy
- extracellular vesicles
- biotherapeutics
- regenerative medicine
- nanomedicine
- wound healing
- cancer-related skin manifestations
- dermatological drug delivery
- wound healing therapeutics
- cutaneous oncology
- exosome-based therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
